These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11208678)

  • 21. Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-kinase/Akt signaling pathway.
    Zhang W; Wang J; Wang H; Tang R; Belcher JD; Viollet B; Geng JG; Zhang C; Wu C; Slungaard A; Zhu C; Huo Y
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1000-6. PubMed ID: 20185792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy.
    Rampler H; Weinhofer I; Netik A; Forss-Petter S; Brown PJ; Oplinger JA; Bugaut M; Berger J
    Mol Genet Metab; 2003 Dec; 80(4):398-407. PubMed ID: 14654352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.
    Minnich A; Tian N; Byan L; Bilder G
    Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E270-9. PubMed ID: 11158930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.
    Rival Y; Benéteau N; Taillandier T; Pezet M; Dupont-Passelaigue E; Patoiseau JF; Junquéro D; Colpaert FC; Delhon A
    Eur J Pharmacol; 2002 Jan; 435(2-3):143-51. PubMed ID: 11821020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of resveratrol-mediated suppression of tissue factor gene expression.
    Pendurthi UR; Meng F; Mackman N; Rao LV
    Thromb Haemost; 2002 Jan; 87(1):155-62. PubMed ID: 11858183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.
    Ramanan S; Kooshki M; Zhao W; Hsu FC; Robbins ME
    Free Radic Biol Med; 2008 Dec; 45(12):1695-704. PubMed ID: 18852043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages.
    Hourton D; Delerive P; Stankova J; Staels B; Chapman MJ; Ninio E
    Biochem J; 2001 Feb; 354(Pt 1):225-32. PubMed ID: 11171098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
    Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
    Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
    Ann SJ; Chung JH; Park BH; Kim SH; Jang J; Park S; Kang SM; Lee SH
    Atherosclerosis; 2015 Jun; 240(2):389-97. PubMed ID: 25881202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
    van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
    J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
    Yamashita M
    Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.
    Jones DC; Ding X; Daynes RA
    J Biol Chem; 2002 Mar; 277(9):6838-45. PubMed ID: 11726654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
    Hirata Y; Masuda Y; Kakutani H; Higuchi T; Takada K; Ito A; Nakagawa Y; Ishii H
    Biochem Pharmacol; 2008 Apr; 75(7):1504-14. PubMed ID: 18261712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver X receptor agonists inhibit tissue factor expression in macrophages.
    Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
    FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.
    Chinetti G; Zawadski C; Fruchart JC; Staels B
    Biochem Biophys Res Commun; 2004 Jan; 314(1):151-8. PubMed ID: 14715259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoic acid selectively inhibits lipopolysaccharide induction of tissue factor gene expression in human monocytes.
    Oeth P; Yao J; Fan ST; Mackman N
    Blood; 1998 Apr; 91(8):2857-65. PubMed ID: 9531596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element/MEK-ERK1/2 pathway.
    Kamimura M; Viedt C; Dalpke A; Rosenfeld ME; Mackman N; Cohen DM; Blessing E; Preusch M; Weber CM; Kreuzer J; Katus HA; Bea F
    Circ Res; 2005 Aug; 97(4):305-13. PubMed ID: 16037570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappaB.
    Chung J; Koyama T; Ohsawa M; Shibamiya A; Hoshi A; Hirosawa S
    Lab Invest; 2007 Jun; 87(6):540-7. PubMed ID: 17401435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity.
    Brown PJ; Winegar DA; Plunket KD; Moore LB; Lewis MC; Wilson JG; Sundseth SS; Koble CS; Wu Z; Chapman JM; Lehmann JM; Kliewer SA; Willson TM
    J Med Chem; 1999 Sep; 42(19):3785-8. PubMed ID: 10508427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.